| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |